Clinical Co-Director, Gynecologic Oncology, Founder and Director, The Oncology Sexual Health Clinic, Massachusetts General Hospital Cancer Center, Associate Professor (pending), Harvard Medical School
Oncology
Dr. Don S. Dizon, MD
|
|
Give Review
Dizon is an expert in the field of Oncology. He studied medicine at University of Rochester School of Medicine and Dentistry. He has 8 awards "America's Top Doctors for Cancer", "America's Top Doctors", "Deans Teaching", "Out of The Blue Outstanding teacher", "Hospital-based Faculty", "Fellow", "Career Development" and "Society for Pediatric Research Fellowship". Dizon has written publications. He has 92 publications published with PubMed. The lastest publication is: 'Chemotherapy in ovarian germ cell tumors: A systematic review.' Dr. Don S. Dizon accepts all Medicare patients.
Publications
- Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus.
- Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.
- Communication About Sexuality in Advanced Illness Aligns With a Palliative Care Approach to Patient-Centered Care.
- Chemotherapy in Ovarian germ cell tumors: A systematic review.
- Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
- Disease-Specific Hashtags for Online Communication About Cancer Care.
- Uterine Sarcoma, Version 1.2016.
- Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary Cancer program.
- Progress and remaining challenges for Cancer control in Latin America and the Caribbean.
- Development of a Breast Cancer Advocacy and Access Health Program in Nicaragua.
- A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyoSarcoma of the uterus: An NRG Oncology/Gynecologic On...
- A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
- Update on the chemotherapeutic management of endometrial Cancer.
- My Father's Final Lesson.
- Advances in the diagnosis and treatment of uterine Sarcomas.
- Narratives in Oncology.
- Improving quality of life in female Cancer survivors: current status and future questions.
- State of the science in cervical Cancer: Where we are today and where we need to go.
- Guilt and the Burden on Oncology Providers.
- Sexual dysfunction in female Cancer survivors.
- Cervical Cancer Prevention: Asian-American Women's Knowledge and Participation in Screening Practices.
- Sexual Health as a Survivorship Issue for Female Cancer Survivors.
- Where do antiangiogenic agents belong in the treatment algorithm for ovarian Cancer?
- The effects of age on treatment and outcomes in women with stages IB1-IIB cervical Cancer.
- Sexual dysfunction in women with Cancer.
- Clear cell Cancer of the ovary.
- Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian Cancer.
- Pushing the bar in treatment of cervical Cancer: what can comprehensive Cancer centers do on their own?
- Is tumor board relevant?
- Preparing for survivorship: quality of life in breast Cancer survivors.
- Practical guidance: the use of social media in oncology practice.
- Novel antiangiogenic therapies in ovarian Cancer.
- Chemotherapy toxicity in gynecologic Cancer patients with a body surface area (BSA)>2 m2.
- Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal Cancer?
- Phase II trial of ixabepilone as second-line treatment in advanced endometrial Cancer: gynecologic oncology group trial 129-P.
- Quality of life after breast Cancer: survivorship and sexuality.
- Frequent pathologic complete responses in aggressive stages II to III breast Cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a...
- Stage IV small bowel carcinoma mimicking advanced ovarian Cancer.
- Advance care planning decisions of women with Cancer: provider recognition and stability of choices.
- Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian Cancer, fallopian tube Cancer, or primary peritoneal Cancer.
- Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.
- HER-dimerization inhibitors: evaluating pertuzumab in women''s Cancers.
- Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's Cancer program.
- Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.
- Treatment options for advanced endometrial carcinoma.
- Sexual ramifications of medical illness.
- Communicating uncertainty can lead to less decision satisfaction: a necessary cost of involving patients in shared decision making?
- Breast Cancer: adjuvant modalities.
- Analysis of patients with epithelial ovarian Cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.
- Retrospective Analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease st...
- Intrahepatic arterial infusion of chemotherapy: clinical results.
- A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor Malignancies.
- The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian Cancer.
- Platinum retreatment of platinum-resistant ovarian Cancer after nonplatinum therapy.
- Treatment of recurrent ovarian Cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The ...
- Clinicopathologic Analysis of early-stage sporadic ovarian carcinoma.
- Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage Ovarian carcinoma.
- Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian Cancer: results of a phase I/II Trial.
- Phase II study of CT-2103 in patients with recurrent epithelial ovarian, Fallopian tube, or primary peritoneal carcinoma.
- Incorporating targeted treatments into standard regimens: whither the role of established doses?
- Dyspnea during thalidomide treatment for advanced ovarian Cancer.
- Breast care in 2011 and beyond: state of policy, state of science.
- Placental mesenchymal dysplasia presenting as a twin gestation with complete molar pregnancy.
- Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, Fallopian tube, and prim...
- Patterns of cellular distribution with the sentinel node positive for breast Cancer.
- Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal Cancer.
- Methods for Chemoprotection and Chemosensitization : MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensiti...
- Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences.
- Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast Cancer survivors: a pilot study.
- The Power of Words.
- Survivorship in Gynecologic Cancer: Enduring the Treatment toward a New Normal.
- Precision medicine and personalized breast Cancer: combination pertuzumab therapy.
- Cross-sensitivity between paclitaxel and docetaxel in a women's Cancers program.
- Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian Cancer.
- Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin.
- Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian Cancer cells by inducing apoptosis: role of caspase and MAPK activation.
- Ovarian Cancer associated with testosterone supplementation in a female-to-male transsexual patient.
- Role of ultrasound-guided axillary fine-needle aspiration in the management of invasive breast Cancer.
- Benzyl isothiocyanate (BITC) induces apoptosis in ovarian Cancer cells in vitro.
- Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
- Oral thalidomide as palliative chemotherapy in women with advanced ovarian Cancer.
- A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
- Does one person provide it all? Primary support and advanced care planning for women with Cancer.
- Clinical characteristics of women presenting with skin-only recurrence of breast Cancer.
- Defining social support systems for women with breast Cancer.
- Sex, intimacy, and the gynecologic oncologists: survey results of the New EnGland Association of Gynecologic Oncologists (NEAGO).
- The differential diagnosis of dyspnea in a woman with metastatic breast Cancer--consideration beyond pulmonary embolism.
- For women receiving chemotherapy for clinically apparent early ovarian Cancer, is there a benefit to surgical staging?
- Society of gynecologic oncologists position paper: breast Cancer care.
- Regional chemotherapy: a focus on hepatic artery infusion for colorectal Cancer liver metastases.
- New-generation platinum agents for solid tumors.
Schools
University Of Rochester School Of Medicine and Dentistry
Yale New Haven Hospital
Memorial Sloan Kettering Cancer Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- America's Top Doctors
- Dean’s Teaching
- Out of The Blue Outstanding teacher
- Hospital-based Faculty
- Fellow
- Career Development
- Society for Pediatric Research Fellowship
Education
-
Memorial Sloan-Kettering Cancer Center -
Yale-New Haven Hospital -
University of Rochester School of Medicine and Dentistry -
University of Rochester
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376573394 |
| Last Name Of The Provider | DIZON |
| First Name Of The Provider | DON |
| View All |
Similar Doctors
|
|
Dr. Kenneth D. Bishop, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie Heon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis J. Cummings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rochelle Strenger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Sikov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kalyan C. Mantripragada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sophia Fircanis, MD
This Doctor is OpenDoctor Recommended.
|